Eugene Schneider Sells Shares of Ionis Pharmaceuticals Inc

Eugene Schneider, EVP and Chief Clinical Development Officer of Ionis Pharmaceuticals Inc, sold 9,549 shares of the company's common stock on August 4, 2025. The shares were sold at a weighted average price of $42.8004 per share, with prices ranging from $42.315 to $43.45. This transaction was executed under a Rule 10b5-1 Trading Plan adopted by Schneider on May 2, 2025. Following the sale, Schneider owns 51,507 shares of Ionis Pharmaceuticals Inc. The sale was reported in a Form 4 filing with the Securities and Exchange Commission.